HighVista Strategies »

Argan shares owned by HighVista Strategies

Quarter-by-quarter ownership of Argan (AGX) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Argan

Tip: Access up to 7 years of quarterly data

All positions including Argan held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Argan by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 7.1k 270.05
2025-06-30 $1.3M 5.7k 220.48
2025-03-31 $1.5M 12k 131.17

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Argan

BlackRock
Vanguard Group
Renaissance Technologies
First Trust Advisors
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
State Street Corporation
Invesco
Susquehanna International
Lord, Abbett & Co
Valiant Capital Management
Arrowstreet Capital, Limited Partnership
AltraVue Capital
Value Aligned Research Advisors

View all funds holding Argan